{
    "clinical_study": {
        "@rank": "143040", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "arm_group_type": "No Intervention", 
                "description": "warm water 3ml po"
            }, 
            {
                "arm_group_label": "treatment group 1", 
                "arm_group_type": "Experimental", 
                "description": "Triple viable Bifidobacterium 0.5 bid po"
            }, 
            {
                "arm_group_label": "treatment group 2", 
                "arm_group_type": "Experimental", 
                "description": "Triple viable Bifidobacterium  0.5 bid po and early Micro-feeding"
            }
        ], 
        "brief_summary": {
            "textblock": "Gut of newborn preterm is sterile,  immediately by the mother and the surrounding\n      environment from microbial colonization. As the effects of diet, intestinal flora is rapidly\n      changed. Preterm children significantly delay in the establishment of normal flora,during\n      hospitalization because of no breastfeeding, use of antibiotics, enteral feeding delay,\n      combat disease and other factors. In this study, hospitalized preterm children for the\n      study, the  prospective randomized double-blind controlled study, to find oral intestinal\n      bifidobacteria and lactobacilli and bifidobacteria subspecies composition and distribution,\n      and further show intestinal bacteria in premature children case group."
        }, 
        "brief_title": "Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Disorder of Stomach Function and Feeding Problems in Newborn", 
            "Feeding and Eating Disorders of Childhood"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Eating Disorders", 
                "Stomach Diseases", 
                "Feeding and Eating Disorders of Childhood"
            ]
        }, 
        "detailed_description": {
            "textblock": "Preterm infants are at high risk of deeding intolerance especially low birth weight infants,\n      Whether oral triple viable Bifidobacterium and early Micro-feeding may improve the symptoms\n      of feeding intolerance.\n\n      84 preterm infants BW(birth weight) less than 2.5kg,entered neonatal intensive care\n      unit(NICU) less than 24 hours and meet the Inclusion Criteria of this study will be Randomly\n      divided into three groups, control group\u3001 treatment group1 (Triple viable Bifidobacterium\n      0.5g bid po)\u3001treatment group2 \uff08Triple viable Bifidobacterium 0.5g bid po and early\n      micro-feeding\uff09. treatment period for more than 1 week. For three groups, feeding\n      symptoms,the traits and frequency of stool of 3 days,1 weeks,2 weeks.And the stool flora\n      measured by PCR."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  preterm with birth weight <2.5kg\n\n        Exclusion Criteria:\n\n          -  Gastrointestinal bleeding and NEC,Kidney,liver function abnormal and have Serious\n             congenital malformation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "24 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02060084", 
            "org_study_id": "SYSD2012021"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "treatment group 1", 
                    "treatment group 2"
                ], 
                "intervention_name": "Triple viable Bifidobacterium 0.5 bid po", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "treatment group 2", 
                "intervention_name": "early Micro-feeding", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "preterm;", 
            "Intestinal flora;", 
            "early Micro-feeding", 
            "Feeding intolerance"
        ], 
        "lastchanged_date": "February 9, 2014", 
        "location": {
            "contact": {
                "email": "mumeer@126.com", 
                "last_name": "Linxia Qiao, MD", 
                "phone": "+8615995687569"
            }, 
            "facility": {
                "address": {
                    "city": "Kunshan", 
                    "country": "China", 
                    "state": "Jiangsu", 
                    "zip": "215300"
                }, 
                "name": "Kunshan First Hospital"
            }, 
            "investigator": {
                "last_name": "Linxia Qiao, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm", 
        "overall_contact": {
            "email": "mumeer@126.com", 
            "last_name": "Linxia Qiao, MD", 
            "phone": "15995687569"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "measure the intestinal flora of three groups and identify the effect of early oral triple viable bifidobacterium  for preterm infants", 
            "measure": "Intestinal flora", 
            "safety_issue": "No", 
            "time_frame": "up to one week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02060084"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kunshan First People's Hospital  Affiliated to Jiangsu University", 
            "investigator_full_name": "Wang Hua", 
            "investigator_title": "Director of pediatric", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "compare the feeding intolerance rate of three groups", 
            "measure": "Feeding intolerance", 
            "safety_issue": "No", 
            "time_frame": "up to one week"
        }, 
        "source": "Kunshan First People's Hospital  Affiliated to Jiangsu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wang Hua", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}